1. Home
  2. BIO vs CAVA Comparison

BIO vs CAVA Comparison

Compare BIO & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$378.68

Market Cap

10.1B

Sector

Industrials

ML Signal

HOLD

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$51.87

Market Cap

10.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
CAVA
Founded
1952
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Restaurants
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
10.6B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
BIO
CAVA
Price
$378.68
$51.87
Analyst Decision
Buy
Buy
Analyst Count
4
23
Target Price
★ $339.75
$91.00
AVG Volume (30 Days)
243.5K
★ 3.2M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 142.61
N/A
EPS
N/A
★ 0.39
Revenue
★ $2,583,200,000.00
$1,179,664,000.00
Revenue This Year
$2.74
$25.71
Revenue Next Year
$3.20
$20.57
P/E Ratio
★ N/A
$137.21
Revenue Growth
0.65
★ 22.41
52 Week Low
$236.73
$43.41
52 Week High
$396.23
$98.79

Technical Indicators

Market Signals
Indicator
BIO
CAVA
Relative Strength Index (RSI) 55.40 33.86
Support Level $364.41 $49.68
Resistance Level $396.23 $74.08
Average True Range (ATR) 9.50 2.21
MACD -1.39 0.09
Stochastic Oscillator 57.47 19.49

Price Performance

Historical Comparison
BIO
CAVA

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.

Share on Social Networks: